Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabine in Virologically Suppressed HIV-1-positive Individuals in Mexico
Clinical trial NCT06907056 · RECRUITING
Trial details
- NCT number
- NCT06907056
- Sponsor
- José Antonio Mata Marín
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-09
- Primary completion
- 2026-02-28
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.